BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26185541)

  • 1. Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment.
    Shervington L; Patil H; Shervington A
    J Cancer; 2015; 6(8):786-94. PubMed ID: 26185541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level.
    Li S; Li W; Chen G; Huang J; Li W
    Am J Transl Res; 2020; 12(8):4749-4756. PubMed ID: 32913547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
    Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
    J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.
    Peng Q; Wang L; Wang S; Wang C; Xue Z
    Neurol Res; 2022 Oct; 44(10):879-887. PubMed ID: 36117461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
    Sauvageot CM; Weatherbee JL; Kesari S; Winters SE; Barnes J; Dellagatta J; Ramakrishna NR; Stiles CD; Kung AL; Kieran MW; Wen PY
    Neuro Oncol; 2009 Apr; 11(2):109-21. PubMed ID: 18682579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
    Canella A; Welker AM; Yoo JY; Xu J; Abas FS; Kesanakurti D; Nagarajan P; Beattie CE; Sulman EP; Liu J; Gumin J; Lang FF; Gurcan MN; Kaur B; Sampath D; Puduvalli VK
    Clin Cancer Res; 2017 Oct; 23(20):6215-6226. PubMed ID: 28679777
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms for hypoxia
    Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chk1/2 inhibitor AZD7762 enhances the susceptibility of IDH-mutant brain cancer cells to temozolomide.
    Ozgiray E; Sogutlu F; Biray Avci C
    Med Oncol; 2022 Aug; 39(11):166. PubMed ID: 35972603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway.
    Chen KC; Chen PH; Ho KH; Shih CM; Chou CM; Cheng CH; Lee CC
    PLoS One; 2019; 14(12):e0225913. PubMed ID: 31805126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
    J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
    PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP90 inhibitors 17-AAG and VER-82576 inhibit porcine deltacoronavirus replication in vitro.
    Zhao Y; Xiao D; Zhang L; Song D; Chen R; Li S; Liao Y; Wen Y; Liu W; Yu E; Wen Y; Wu R; Zhao Q; Du S; Wen X; Cao S; Huang X
    Vet Microbiol; 2022 Feb; 265():109316. PubMed ID: 34954542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
    Liu N; Hu G; Wang H; Li Z; Guo Z
    J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer.
    Ma L; Sato F; Sato R; Matsubara T; Hirai K; Yamasaki M; Shin T; Shimada T; Nomura T; Mori K; Sumino Y; Mimata H
    Oncol Rep; 2014 Jun; 31(6):2482-92. PubMed ID: 24718854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the heat shock response in Arabidopsis by heat shock protein 70 inhibitor VER-155008.
    Matsuoka E; Kato N; Hara M
    Funct Plant Biol; 2019 Sep; 46(10):925-932. PubMed ID: 31217072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer.
    Prince T; Ackerman A; Cavanaugh A; Schreiter B; Juengst B; Andolino C; Danella J; Chernin M; Williams H
    Oncotarget; 2018 Aug; 9(66):32702-32717. PubMed ID: 30220976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
    Krishnamoorthy GP; Guida T; Alfano L; Avilla E; Santoro M; Carlomagno F; Melillo RM
    J Biol Chem; 2013 Jun; 288(24):17481-94. PubMed ID: 23629654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
    Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K
    Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
    Yin H; Cui X
    Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
    [No Abstract]   [Full Text] [Related]  

  • 20. The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma.
    Chatterjee M; Andrulis M; Stühmer T; Müller E; Hofmann C; Steinbrunn T; Heimberger T; Schraud H; Kressmann S; Einsele H; Bargou RC
    Haematologica; 2013 Jul; 98(7):1132-41. PubMed ID: 23065523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.